Skip to main content

Pharmacotherapy of social anxiety disorder.

Publication ,  Journal Article
Davidson, JR
Published in: J Clin Psychiatry
1998

Antidepressants and high-potency benzodiazepines have been used successfully to treat patients with social anxiety disorder. This review considers the efficacy of irreversible and reversible inhibitors of monoamine oxidase, selective serotonin reuptake inhibitors, high-potency benzodiazepines, and beta-blockers and presents the response rates for each of these classes. Aspects of the social anxiety syndrome that are sensitive to drug treatment are discussed, and the data relating to relapse following treatment discontinuation are presented. Predictors for negative treatment outcome following completion of acute treatment trials are reviewed.

Duke Scholars

Published In

J Clin Psychiatry

ISSN

0160-6689

Publication Date

1998

Volume

59 Suppl 17

Start / End Page

47 / 53

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Selective Serotonin Reuptake Inhibitors
  • Recurrence
  • Psychiatry
  • Prognosis
  • Phobic Disorders
  • Multicenter Studies as Topic
  • Monoamine Oxidase Inhibitors
  • Humans
  • Clinical Trials as Topic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Davidson, J. R. (1998). Pharmacotherapy of social anxiety disorder. J Clin Psychiatry, 59 Suppl 17, 47–53.
Davidson, J. R. “Pharmacotherapy of social anxiety disorder.J Clin Psychiatry 59 Suppl 17 (1998): 47–53.
Davidson JR. Pharmacotherapy of social anxiety disorder. J Clin Psychiatry. 1998;59 Suppl 17:47–53.
Davidson, J. R. “Pharmacotherapy of social anxiety disorder.J Clin Psychiatry, vol. 59 Suppl 17, 1998, pp. 47–53.
Davidson JR. Pharmacotherapy of social anxiety disorder. J Clin Psychiatry. 1998;59 Suppl 17:47–53.

Published In

J Clin Psychiatry

ISSN

0160-6689

Publication Date

1998

Volume

59 Suppl 17

Start / End Page

47 / 53

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Selective Serotonin Reuptake Inhibitors
  • Recurrence
  • Psychiatry
  • Prognosis
  • Phobic Disorders
  • Multicenter Studies as Topic
  • Monoamine Oxidase Inhibitors
  • Humans
  • Clinical Trials as Topic